24.06.2015 • News

Americans Blame Drugmakers for High Prices

© Nikolai Sorokin - Fotolia.com
© Nikolai Sorokin - Fotolia.com

Americans are far more likely to blame pharmaceutical companies for high prescription medication costs than their health insurers, a recent poll has found. Of the 1,200 adults interviewed by the Kaiser Family Foundation’s researchers for the June Kaiser Health Tracking Poll, around three-quarters said the cost of prescription drug costs was unreasonable, but only10% of those responding blamed the high prices on co-pays demanded by their insurance company.

A similar majority said drug profits were a major factor in prescription prices, and 87% approved of enabling the Medicare program to negotiate prices with producers.

At the same time, over 70% of the poll’s respondents said they thought insurers should always pay for an expensive drug recommended by a doctor when no lower-cost alternative exists.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.